Mirum Pharmaceuticals Inc (MIRM) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mirum Pharmaceuticals Inc   (NASDAQ: MIRM)


Mirum Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mirum Pharmaceuticals Inc's ROI in the third quarter of 2026?
Mirum Pharmaceuticals Inc recorded a cumulative net loss of $-904 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -121.75%.

Within the Healthcare sector 646 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3772 to 4103.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 23.07 % 21.82 % 22.77 % 21.17 % 9.37 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 744 822 618 786 625
Return On Investment (TTM) -121.75 % -120.69 % -117.91 % -3.52 % -6.87 %
MIRM's Overall Ranking # 4103 # 3772 # 2270 # 2849 #
Seq. Investment Change TTM 4.17 % 5.2 % 2.09 % 10.02 % 3.1 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -904 -860 -799 -23 -41

MIRM Company Profile >> Back to MIRM Roi Comparisons >> See Annual MIRM Return On Investment



Return On Investment MIRM's Ranking
Within: No.
Industry # 289
Sector # 647
Overall # 4103

Return On Investment Statistics
High Average Low
-3.73 %
-42.43 %
-125.11 %
(Dec 31 2025)   (Jun 30 2026)







Financial Statements
Mirum Pharmaceuticals Inc's III. Quarter Investments $ 744 Millions MIRM's Balance sheet
Mirum Pharmaceuticals Inc's III. Quarter Income $ -41 Millions Quarterly MIRM's Income Statement
MIRM's Income by Division See MIRM's Income by Division


MIRM Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 637 544 560 288 252
Y / Y Investment Growth 17.05 % -2.74 % 94.17 % 14.33 % 13.33 %
Net Income in Millions -23 -88 -163 -136 -84
Y / Y Net Income Growth - - - - -
Annual Return On Investment -3.67 % -16.16 % -29.2 % -47.08 % -33.32 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MIRM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MIRM's Competitors
Subscribers only: Roi for Mirum Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for MIRM's Customers

Other Ratios
MIRM's Roa MIRM's Inventory Turnover Ratio MIRM's Growth Rates MIRM's Dividend Statistics
MIRM's Profitability Ratios MIRM's Asset Turnover Ratio MIRM's Dividend Growth
MIRM's Roe MIRM's Valuation Ratios MIRM's Financial Strength Ratios MIRM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-04T15:20:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.